Kawai Nobuyuki, Nishiyama Yoshihiro, Miyake Keisuke, Tamiya Takashi, Nagao Seigo
Department of Neurological Surgery, Kagawa University School of Medicine, 1750-1 Miki-cho, Kita-gun, Kagawa 761-0793, Japan.
Ann Nucl Med. 2005 Dec;19(8):685-90. doi: 10.1007/BF02985117.
Although 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) has been used as a promising tool to diagnose primary central nervous system lymphoma (PCNSL) because the tumor shows very high FDG accumulation, no data exist evaluating the extent of tumor FDG transport and metabolism. The aim of this study was to evaluate the feasibility of FDG-PET kinetic analysis in measurement of uptake parameters of FDG in the lymphoma tissues and in the assessment of treatment effects in patients with PCNSL.
Dynamic FDG-PET examination was performed in 7 histologically proven PCNSL patients before and after methotrexate-based chemotherapy.
Before the chemotherapy, the highest CMRglc in the tumor for all 7 patients was 79.4 +/- 27.2 micromol/100 g/min. This value was significantly higher than that observed in the normal cortex in 14 control patients (44.3 +/- 6.0 micromol/100 g/min, p < 0.001). The phosphorylation (k3) activity was also significantly higher in the tumor (0.093 +/- 0.026 min(-1)) compared with the normal cortex (0.064 +/- 0.014 min(-1), p < 0.05). On the other hand, the transporter (K1) activity in the tumor (0.079 +/- 0.016 ml/min) was similar to that observed in the normal cortex (0.082 +/- 0.012 ml/min). The chemotherapy significantly reduced the volume of the tumor in 6 of 7 patients and the highest CMRglc in the tumor examined 18.0 +/- 5.5 days after the chemotherapy (34.0 +/- 21.8 micromol/100 g/min) was significantly lower than that observed before the chemotherapy (p < 0.01). This reduction in FDG uptake was concomitant with a significant reduction in both the K1 and k3 values (p < 0.05). The reduction in the k3 value after the chemotherapy was marked in 6 of 7 patients in whom the tumor responded to the first chemotherapy.
Dynamic image acquisition can separate regional FDG uptake into FDG transport and phosphorylation activity in the lymphoma tissues. Tumor FDG uptake was significantly higher with accelerated phosphorylation activity compared with that observed in the normal cortex.
尽管18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描(PET)已被用作诊断原发性中枢神经系统淋巴瘤(PCNSL)的一种有前景的工具,因为该肿瘤显示出非常高的FDG摄取,但尚无数据评估肿瘤FDG转运和代谢的程度。本研究的目的是评估FDG-PET动力学分析在测量淋巴瘤组织中FDG摄取参数以及评估PCNSL患者治疗效果方面的可行性。
对7例经组织学证实的PCNSL患者在基于甲氨蝶呤的化疗前后进行了动态FDG-PET检查。
化疗前,所有7例患者肿瘤中的最高葡萄糖代谢率(CMRglc)为79.4±27.2微摩尔/100克/分钟。该值显著高于14例对照患者正常皮质中的观察值(44.3±6.0微摩尔/100克/分钟,p<0.001)。与正常皮质(0.064±0.014分钟-1,p<0.05)相比,肿瘤中的磷酸化(k3)活性也显著更高(0.093±0.026分钟-1)。另一方面,肿瘤中的转运体(K1)活性(0.079±0.016毫升/分钟)与正常皮质中的观察值(0.082±0.012毫升/分钟)相似。化疗使7例患者中的6例肿瘤体积显著减小,化疗后18.0±5.5天检查的肿瘤中最高CMRglc(34.0±21.8微摩尔/100克/分钟)显著低于化疗前观察到的值(p<0.01)。FDG摄取的这种降低与K1和k3值的显著降低同时出现(p<0.05)。在7例肿瘤对首次化疗有反应的患者中,有6例化疗后k3值降低明显。
动态图像采集可将淋巴瘤组织中的区域FDG摄取分为FDG转运和磷酸化活性。与正常皮质相比,肿瘤FDG摄取因磷酸化活性加速而显著更高。